Filter
281
Text search:
molecular
markers
Featured
Recommendations
43
New Publications
55
Language
Document type
No document type
119
Guidelines
68
Studies & Reports
53
Manuals
18
Fact sheets
9
Strategic & Response Plan
7
Training Material
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
32
Global
13
Latin America and the Carribbean
9
Kenya
7
Africa
6
South Africa
5
Brazil
3
Sierra Leone
2
Philippines
2
Pakistan
2
Tanzania
2
West and Central Africa
2
South–East Asia Region
2
Asia
2
Venezuela
2
Vietnam
2
North America
2
Liberia
1
Nigeria
1
Congo, Democratic Republic of
1
USA
1
Ethiopia
1
Cameroon
1
Ghana
1
Zimbabwe
1
Nepal
1
Afghanistan
1
Zambia
1
Syria
1
Cambodia
1
Thailand
1
China
1
Malawi
1
Benin
1
Peru
1
Myanmar / Burma
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Laos
1
Georgia
1
Authors & Publishers
Publication Years
Category
Countries
69
Clinical Guidelines
51
Public Health
24
Pharmacy & Technologies
15
Women & Child Health
4
Key Resources
4
Capacity Building
3
Toolboxes
COVID-19
34
TB
28
Malaria
24
Mental Health
21
HIV
18
NTDs
17
AMR
14
NCDs
14
Rapid Response
8
Ebola & Marburg
5
Refugee
4
Pharmacy
4
2.0 Rapid Response
4
Planetary Health
3
Disability
2
Cholera
2
Specific Hazards
2
Polio
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
PLoS Negl Trop Dis 18(7): e0012282.
This review highlights common diagnostic
approaches for detecting schistosomiasis in field and clinical settings, major challenges,
and provides new and novel opportunities and diagnosis pathways that will be critical in sup-
porting elimination of schistosomi
...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio
...
Asthma is the most common chronic disease in children, imposing a consistent burden on health system. In recent years, prevalence of asthma symptoms became globally increased in children and adolescents, particularly in Low-Middle Income Countries (LMICs). Host (genetics, atopy) and environmental fa
...
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
The Lancet Regional Health - Americas 2024;36: 100821 https://doi.org/10.1016/j.lana.2024.100821
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic
...
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex A. Quantitative evidence reports
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover
...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
Review Article:
The American Journal of the Medical Sciences 2011;341(6):493–498.]
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
WHO guidelines on meningitis diagnosis, treatment and care. Web Annex C. Evidence-to-Decision frameworks
recommended
The guidelines are primarily intended for health-care professionals working in first- or second-level health-care facilities, including emergency, inpatient and outpatient services. They are also directed at policy-makers, health-care planners and programme managers, academic institutions, non-gover
...
Meeting report, Kampala, Uganda,
7–8 November 2023
Launch of the WHO Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010–2019). Key findings
